Monoclonal Antibodies in Cancer Therapy
- 1 March 1996
- journal article
- review article
- Published by Springer Nature in Clinical Immunotherapeutics
- Vol. 5 (3) , 214-222
- https://doi.org/10.1007/bf03259084
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Status of Bispecific Monoclonal Antibodies for Cancer TherapyClinical Immunotherapeutics, 1996
- Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinomaThe Lancet, 1994
- Monoclonal antibodies in cancer therapyCurrent Opinion in Immunology, 1993
- Differential Expression of Proliferation-Associated Molecules in Individual Micrometastatic Carcinoma CellsJNCI Journal of the National Cancer Institute, 1993
- A randomized controlled trial of adjuvant immunotherapy (murine monoclonal antibody 494/32) in resectable pancreatic cancerCancer, 1991
- Cytokine effects and role of adhesive proteins and Fc receptors in human macrophage-mediated antibody dependent cellular cytotoxicityJournal of Cellular Biochemistry, 1991
- Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon CarcinomaNew England Journal of Medicine, 1990
- Monoclonal antibodies in cancer therapyCurrent Opinion in Immunology, 1990
- Human Macrophages Armed with Murine Immunoglobulin G2a Antibodies to Tumors Destroy Human Cancer CellsScience, 1983
- ComplementAnnual Review of Biochemistry, 1975